Valneva SE (LON:0OB3)
London · Delayed Price · Currency is GBP · Price in EUR 3.878
+0.053 (1.39%)
At close: Sep 12, 2025
Valneva SE Market Cap
Valneva SE has a market cap or net worth of 567.67 million as of September 16, 2025. Its market cap has increased by 54.66% in one year.
Market Cap
567.67M
Enterprise Value
598.47M
Revenue
168.29M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.88
Market Cap Chart
Since June 29, 2007, Valneva SE's market cap has increased from 66.74M to 567.67M, an increase of 750.60%. That is a compound annual growth rate of 12.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 567.67M | 95.51% |
| Dec 31, 2024 | 290.35M | -48.92% |
| Dec 29, 2023 | 568.46M | -25.57% |
| Dec 30, 2022 | 763.80M | -64.68% |
| Dec 31, 2021 | 2.16B | 242.35% |
| Dec 31, 2020 | 631.58M | 219.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 182.89B |
| GSK plc | 60.53B |
| Haleon | 32.39B |
| Smith & Nephew | 12.20B |
| ConvaTec Group | 4.78B |
| Hikma Pharmaceuticals | 3.61B |
| HUTCHMED (China) | 2.23B |
| Genus | 1.72B |